These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29788258)

  • 21. Screening for primary aldosteronism in a primary care unit.
    Volpe C; Wahrenberg H; Hamberger B; Thorén M
    J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):212-9. PubMed ID: 23118039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
    Verheyen N; Fahrleitner-Pammer A; Pieske B; Meinitzer A; Belyavskiy E; Wetzel J; Gaksch M; Grübler MR; Catena C; Sechi LA; Van Ballegooijen AJ; Brandenburg VM; Scharnagl H; Perl S; Brussee H; März W; Pilz S; Tomaschitz A
    J Hypertens; 2016 Sep; 34(9):1778-86. PubMed ID: 27379537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs.
    Huang X; Li J; Liu L; Chen G; Yi Y; Li P; Wu Y; Xu Y; Bao H; Yu L; Qin X; Zhang Y; Wang B; Li J; Fan Hou F; Huo Y; Cheng X; Spence JD
    Hypertens Res; 2019 Dec; 42(12):1971-1978. PubMed ID: 31562418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aldosterone and refractory hypertension: a prospective cohort study.
    Sartori M; Calò LA; Mascagna V; Realdi A; Macchini L; Ciccariello L; De Toni R; Cattelan F; Pessina AC; Semplicini A
    Am J Hypertens; 2006 Apr; 19(4):373-9; discussion 380. PubMed ID: 16580572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study.
    Maiolino G; Rossitto G; Bisogni V; Cesari M; Seccia TM; Plebani M; Rossi GP;
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28529209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
    Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma renin activity and aldosterone concentration are not altered by the novel calcium channel antagonist, azelnidipine, in hypertensive patients.
    Kondo T; Goto R; Sonoda K; Yasuda T; Ono K; Takaki Y; Yatsuda R; Miyamura N; Araki E
    Intern Med; 2010; 49(7):637-43. PubMed ID: 20371952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical relevance of dietary salt intake on aldosterone and the aldosterone-to-renin ratio as screening parameters for primary aldosteronism.
    Koch M; Aker S; Haastert B; Rump LC
    Clin Nephrol; 2010 Sep; 74(3):182-9. PubMed ID: 20860902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aldosterone-to-renin ratio and home blood pressure in subjects with higher and lower sodium intake: the Ohasama study.
    Satoh M; Kikuya M; Hara A; Ohkubo T; Mori T; Metoki H; Utsugi MT; Hirose T; Obara T; Inoue R; Asayama K; Totsune K; Hoshi H; Satoh H; Imai Y
    Hypertens Res; 2011 Mar; 34(3):361-6. PubMed ID: 21124331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism.
    Jansen PM; van den Born BJ; Frenkel WJ; de Bruijne EL; Deinum J; Kerstens MN; Smulders YM; Woittiez AJ; Wijbenga JA; Zietse R; Danser AH; van den Meiracker AH
    J Hypertens; 2014 Jan; 32(1):115-26. PubMed ID: 24018605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aldosterone response to antihypertensive treatment.
    de Leeuw PW; van Soest GA; Birkenhäger WH
    Clin Exp Hypertens A; 1982; 4(9-10):1913-21. PubMed ID: 6291819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tagging SNPs in REN, AGTR1 and AGTR2 genes and response of renin activity, angiotensin II and aldosterone concentrations to antihypertensive treatment in Kazakans.
    Yan W; Zhang Y; Shan Z; Wang Q; Huang Y; Wang C; Yan K
    J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):581-7. PubMed ID: 21810897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of sodium-glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study.
    Sawamura T; Karashima S; Nagase S; Nambo H; Shimizu E; Higashitani T; Aono D; Ohbatake A; Kometani M; Demura M; Furukawa K; Takeda Y; Yoneda T
    BMC Endocr Disord; 2020 Nov; 20(1):177. PubMed ID: 33256676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
    Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.